# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4646356 | 45, LSP12-3129 | INH | 0 | ALA4630284 | Not Active | % | Homo sapiens | ||||
2. | FR 139317 | 32 | INH | 0 | ALA4630279 | Not Active | % | Homo sapiens | ||||
3. | ALA4646356 | 45, LSP12-3129 | INH | = | 49 | % | ALA4630278 | % | Homo sapiens | |||
4. | Fmoc-Leu-OH | FMOC-leucine | INH | = | 55 | % | ALA4630277 | % | Homo sapiens | |||
5. | ALA4280954 | 1; Neu5Ac | Activity | = | 130 | % | ALA4630276 | % | Homo sapiens | |||
6. | Fmoc-Leu-OH | FMOC-leucine | Ki | = | 10.2 | uM | ALA4630275 | 4.99 | nM | Homo sapiens | ||
7. | ALA4646356 | 45, LSP12-3129 | Ki | = | 7.8 | uM | ALA4630275 | 5.11 | nM | Homo sapiens | ||
8. | ALA4646356 | 45, LSP12-3129 | Km | = | 1.7 | mM | ALA4630274 | nM | Homo sapiens | |||
9. | ALA4646356 | 45, LSP12-3129 | INH | = | 31 | % | ALA4630273 | % | Homo sapiens | |||
10. | Fmoc-Leu-OH | FMOC-leucine | Km | = | 1.3 | mM | ALA4630272 | nM | Homo sapiens | |||
11. | Fmoc-Leu-OH | FMOC-leucine | INH | = | 56 | % | ALA4630271 | % | Homo sapiens | |||
12. | Fmoc-Leu-OH | FMOC-leucine | INH | = | 100 | % | ALA4630267 | % | Homo sapiens | |||
13. | FR 139317 | 32 | Ratio | = | 50 | ALA4630262 | Homo sapiens | |||||
14. | ALA4646356 | 45, LSP12-3129 | Ratio | = | 400 | ALA4630262 | Homo sapiens | |||||
15. | Fmoc-Lys(Fmoc)-OH | 24 | INH | 0 | ALA4630261 | Not Active | % | Homo sapiens | ||||
16. | Fmoc-Pro-OH | 23 | INH | 0 | ALA4630261 | Not Active | % | Homo sapiens | ||||
17. | Fmoc-Cys(Bzl)-OH | 22 | INH | 0 | ALA4630261 | Not Active | % | Homo sapiens | ||||
18. | ALA4643679 | 21 | INH | 0 | ALA4630261 | Active | % | Homo sapiens | ||||
19. | N-Fmoc-S-(4-methoxybenzyl)-L-cysteine | 20 | INH | 0 | ALA4630261 | Active | % | Homo sapiens | ||||
20. | Fmoc-lle-OH | Fmoc-L-isoleucine | INH | 0 | ALA4630261 | Active | % | Homo sapiens |